
Turning Technology to Patient Benefit: Challenges and Key Learnings with John Carlos Diaz, Clinical Research and Strategy Lead at GeoSera LLC
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
In this episode of theSpark, Andy Lipetz and John Carlos Diaz, Clinical Research and Strategy Lead at GeoSera LLC, sit down and chat about his move from large pharma to small pharma, and ultimately started GeoSera Consulting.
Covered in this Episode:
- The regulations from FDA and other regulatory bodies is not black or white
- Clinical trials education and timing: why it’s crucial to get it right the first time
- Making your trial more attractive and winning at participation through reduced patient and site burden
- Leveraging on technology for better patient compliance in clinical trials
Listen to our latest podcast episode now!
Are you a sponsor looking for technology solutions to democratize your trials? Visit our website at https://www.castoredc.com/ for more information
Pas encore de commentaire